Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NKTR stock hub

Nektar Therapeutics has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NKTRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NKTR

In the news

Latest news · NKTR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-53.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-173.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NKTR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000906709
Company name	Nektar Therapeutics
Country	United States
Country code	US
Cusip	640268306
Employees	63
Employees Change	2%
Employees Change Percent	3.28
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1994-05-03
Isin	US6402683063
Last refreshed	2026-05-10
Market cap	$2.8B
Market cap category	Mid-Cap
Price	$81.89
Price currency	USD
Rev Per Employee	883,063.49x
Sector	Healthcare
Sic	2834
Symbol	NKTR
Website	https://www.nektar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.72%
EV Sales Forward	51.75x
EV/Sales	39.1x
P/B ratio	3.52x
P/S ratio	49.67x
PS Forward	65.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-224.08%
EBITDA Margin	-222.54%
Gross margin	100%
Gross Profit	$55.6M
Gross Profit Growth	-14.54%
Gross Profit Growth Q	3.83%
Gross Profit Growth3 Y	-5.27%
Gross Profit Growth5 Y	-11.86%
Net Income	$-158.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-284.41%
Profit Margin	-284.18%
Profit Per Employee	$-2.5M
ROA	-15.28
Roa5y	-20.76
ROCE	-17.67
ROE	-53.6
Roe5y	-116.6
ROIC	-173.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.58%
Cagr15y	-4%
Cagr1y	802.84%
Cagr20y	-6.89%
Cagr3y	88.2%
Cagr5y	-22.95%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-36.24x
Revenue Growth Q	3.83x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-14.44x
Revenue Growth5 Y	-15.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.11
Assets	$763.3M
Cash	$568.6M
Current Assets	$589M
Current Liabilities	$57.7M
Debt	$143.4M
Debt Equity	$0.25
Equity	$576.2M
Interest Coverage	-4.28
Liabilities	$187.1M
Long Term Assets	$174.2M
Long Term Liabilities	$129.3M
Net Cash	$588.2M
Net Cash By Market Cap	$21.29
Net Cash Growth	1,630.3%
Net Debt Equity	$-1.02
Tangible Book Value	$576.2M
Tangible Book Value Per Share	$23.29
WACC	11.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.21
Net Working Capital	$-14.7M
Quick ratio	9.85
Working Capital	$531.3M
Working Capital Turnover	$0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-59.2%
1Y total return	801.48%
200-day SMA	55.25
3Y total return	566.91%
50-day SMA	78.22
50-day SMA vs 200-day SMA	50over200
5Y total return	-72.84%
All Time High	1,670.4
All Time High Change	-95.1%
All Time High Date	2018-03-12
All Time Low	6.19
All Time Low Change	1,223.15%
All Time Low Date	2023-11-13
ATR	4.93
Beta	1.25
Beta1y	4.82
Beta2y	3.66
Ch YTD	93.69
High	84.94
High52	109
High52 Date	2026-04-20
High52ch	-24.87%
Low	80.91
Low52	7.99
Low52 Date	2025-06-16
Low52ch	924.91%
Ma50ch	4.7%
Premarket Change Percent	2.44
Premarket Price	$85.4
Premarket Volume	2,397
Price vs 200-day SMA	48.22%
RSI	48.16
RSI Monthly	65.25
RSI Weekly	64.01
Sharpe ratio	1.75x
Sortino ratio	6.49
Total Return	-39.76%
Tr YTD	93.69
Tr15y	-45.79%
Tr1m	7.41%
Tr1w	-5.29%
Tr3m	122.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	5
Analyst Price Target Top	$146
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.53
Earnings Revenue Estimate	10,829,152x
Earnings Revenue Estimate Growth	3.53x
Operating Income	$-124.7M
Operating margin	-224.1
Price target	$153
Price Target Change	$87.01
Price Target Change Top	$78.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,651,829%
Float Percent	93.81%
Shares Insiders	0.39%
Shares Institutions	63.36%
Shares Out	33,742,147
Shares Qo Q	21.87%
Shares Yo Y	39.76%
Short Float	11.47%
Short Ratio	4.77
Short Shares	10.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,240,723.45x
Bv Per Share	23.29
Ch10y	-59.2
Ch15y	-45.79
Ch1m	7.41
Ch1w	-5.29
Ch1y	801.5
Ch20y	-76
Ch3m	122.5
Ch3y	566.9
Ch5y	-72.84
Ch6m	46.31
Change	-1.78%
Change From Open	-3.59
Close	83.37
Days Gap	1.88
Depreciation Amortization	856,500
Dollar Volume	59,175,843.1
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-124.7M
EBITDA	$-123.8M
EPS	$-8.09
F Score	3
Fiscal Year End	December
Founded	1,990
Income Tax	$-126,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-06-09
Last Split Type	Reverse
Last10k Filing Date	2026-03-13
Ma150	61.37
Ma150ch	33.45%
Ma20	86.75
Ma20ch	-5.61%
Next Earnings Date	2026-08-06
Open	84.94
Optionable	Yes
Position In Range	24.32
Post Close	81.89
Postmarket Change Percent	0.13
Postmarket Price	$82
Pre Close	83.37
Price Date	2026-05-08
Ptbv Ratio	4.8
Relative Volume	0.58x
Revenue	55,633,000x
Tax By Revenue	-0.23x
Tr20y	-76%
Tr6m	46.31%
Us State	California
Volume	722,626
Z Score	-3.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NKTR pay a dividend?

Capital-return profile for this ticker.

Performance

NKTR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NKTR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+63.4%

Float: +93.8% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NKTR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

+48.2%

50/200-day relationship not available

Beta (5Y)

1.25

More volatile than the market

Sharpe ratio

1.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NKTR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NKTR stock rating?

Nektar Therapeutics is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NKTR analysis?

The full report lives at /stocks/NKTR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NKTR?

The latest report frames NKTR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NKTR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.